首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   84945篇
  免费   6038篇
  国内免费   332篇
耳鼻咽喉   1083篇
儿科学   2011篇
妇产科学   1272篇
基础医学   10178篇
口腔科学   2046篇
临床医学   9451篇
内科学   17914篇
皮肤病学   1652篇
神经病学   7925篇
特种医学   2829篇
外科学   13594篇
综合类   1087篇
一般理论   94篇
预防医学   7066篇
眼科学   1620篇
药学   5618篇
  2篇
中国医学   82篇
肿瘤学   5791篇
  2023年   341篇
  2022年   526篇
  2021年   1511篇
  2020年   884篇
  2019年   1517篇
  2018年   1777篇
  2017年   1349篇
  2016年   1552篇
  2015年   1739篇
  2014年   2476篇
  2013年   3552篇
  2012年   5437篇
  2011年   5861篇
  2010年   3177篇
  2009年   2952篇
  2008年   5198篇
  2007年   5376篇
  2006年   5347篇
  2005年   5379篇
  2004年   5055篇
  2003年   4809篇
  2002年   4545篇
  2001年   1404篇
  2000年   1377篇
  1999年   1369篇
  1998年   1018篇
  1997年   842篇
  1996年   768篇
  1995年   764篇
  1994年   623篇
  1993年   565篇
  1992年   898篇
  1991年   856篇
  1990年   801篇
  1989年   680篇
  1988年   696篇
  1987年   649篇
  1986年   654篇
  1985年   659篇
  1984年   554篇
  1983年   528篇
  1982年   537篇
  1981年   495篇
  1980年   382篇
  1979年   420篇
  1978年   367篇
  1977年   313篇
  1976年   232篇
  1974年   268篇
  1973年   256篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
The hepatitis C virus (HCV) is a pandemic human pathogen posing a substantial health and economic burden in both developing and developed countries. Controlling the spread of HCV through behavioural prevention strategies has met with limited success and vaccine development remains slow. The development of antiviral therapeutic agents has also been challenging, primarily due to the lack of efficient cell culture and animal models for all HCV genotypes, as well as the large genetic diversity between HCV strains. On the other hand, the use of interferon-α-based treatments in combination with the guanosine analogue, ribavirin, achieved limited success, and widespread use of these therapies has been hampered by prevalent side effects. For more than a decade, the HCV RNA-dependent RNA polymerase (RdRp) has been targeted for antiviral development. Direct acting antivirals (DAA) have been identified which bind to one of at least six RdRp inhibitor-binding sites, and are now becoming a mainstay of highly effective and well tolerated antiviral treatment for HCV infection. Here we review the different classes of RdRp inhibitors and their mode of action against HCV. Furthermore, the mechanism of antiviral resistance to each class is described, including naturally occurring resistance-associated variants (RAVs) in different viral strains and genotypes. Finally, we review the impact of these RAVs on treatment outcomes with the newly developed regimens.  相似文献   
33.
34.
35.
36.
We consider the scenario where there is an exposure, multiple biologically defined sets of biomarkers, and an outcome. We propose a new two-step procedure that tests if any of the sets of biomarkers mediate the exposure/outcome relationship, while maintaining a prespecified familywise error rate. The first step of the proposed procedure is a screening step that removes all groups that are unlikely to be strongly associated with both the exposure and the outcome. The second step adapts recent advances in postselection inference to test if there are true mediators in each of the remaining candidate sets. We use simulation to show that this simple two-step procedure has higher statistical power to detect true mediating sets when compared with existing procedures. We then use our two-step procedure to identify a set of Lysine-related metabolites that potentially mediate the known relationship between increased body mass index and the increased risk of estrogen-receptor positive breast cancer in postmenopausal women.  相似文献   
37.
Sirt5 is known to functionally regulate mitochondrial proteins by altering posttranslational modifications, including lysine desuccinylation. While roles for Sirt5 as either a tumor promoter or suppressor, or in chemoresistance, have been implicated in other cancers, the function of Sirt5 in cutaneous melanoma has not been well examined. Therefore, to determine whether Sirt5 is necessary for BrafV600E‐mediated melanoma formation and/or disease progression, we crossed a genetically engineered murine melanoma model (TyrCreERT2/+; BrafLSLV600E/+; Ptenflox/flox) to Sirt5?/? knockout animals. In addition, we tested for synergism with a selective BRAF (V600E) inhibitor in Sirt5?/? mouse melanoma cells. Taken together, this report demonstrates that, in these models, Sirt5 is dispensable for BrafV600E‐mediated cutaneous melanoma formation and growth in vivo, and does not improve sensitivity to a selective BRAF inhibitor.  相似文献   
38.
Quality of Life Research - Health-related quality of life (HRQoL) is an important indicator of population health, yet no age-specific trend analyses in HRQoL have been conducted with a nationally...  相似文献   
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号